Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection, Human Immunodeficiency Virus I”

725 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 725 results

Testing effectiveness (Phase 2)Ended earlyNCT00102778
What this trial is testing

GW873140 In Combination With Kaletra In HIV Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 175
Early research (Phase 1)Study completedNCT00000984
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40
Early research (Phase 1)Study completedNCT00040274
What this trial is testing

DPC 817 in HIV-Infected Males

Who this might be right for
HIV Infections
Pharmasset 30
Early research (Phase 1)Study completedNCT00001055
What this trial is testing

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 76
Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT00001785
What this trial is testing

Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)

Who this might be right for
HTLV-I InfectionSpinal Cord DiseaseTropical Spastic Paraparesis
National Institute of Neurological Disorders and Stroke (NINDS) 12
Early research (Phase 1)Study completedNCT00774735
What this trial is testing

GSK1349572 Drug Interaction Study With Protease Inhibitors

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 30
Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Not applicableStudy completedNCT00253682
What this trial is testing

Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers

Who this might be right for
Cardiovascular DiseasesHeart DiseasesAtherosclerosis+2 more
University of Miami 167
Large-scale testing (Phase 3)Study completedNCT01227824
What this trial is testing

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 828
Early research (Phase 1)Study completedNCT00321061
What this trial is testing

Phase I Study of Vaccination Schedule of Experimental HIV Vaccines

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00000642
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Early research (Phase 1)Study completedNCT00000954
What this trial is testing

Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Not applicableStudy completedNCT00002299
What this trial is testing

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Hoffmann-La Roche
Early research (Phase 1)Study completedNCT00107549
What this trial is testing

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00528489
What this trial is testing

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT00623597
What this trial is testing

Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children.

Who this might be right for
HIV Infections
Hoffmann-La Roche 18
Early research (Phase 1)Study completedNCT01266616
What this trial is testing

Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 62
Early research (Phase 1)Study completedNCT00040300
What this trial is testing

A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

Who this might be right for
HIV Infections
Pharmasset 18
Load More Results